Skip to content

Dexamethasone Tolerability in the Treatment of Acute Asthma in Children

Dexamethasone Tolerability in the Treatment of Acute Asthma in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00973687
Enrollment
430
Registered
2009-09-09
Start date
2004-09-30
Completion date
2006-05-31
Last updated
2015-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

pediatric, dexamethasone, management, corticosteroids, asthma

Brief summary

The purpose of this study is to assess whether smaller volumes of oral dexamethasone result in better tolerability, specifically less vomiting, in pediatric patients during an acute asthma exacerbation.

Interventions

DRUGOra Sweet

A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.

DRUGDexamethasone

Sponsors

IWK Foundation
CollaboratorUNKNOWN
IWK Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* acute asthma exacerbation * requiring oral systemic corticosteroids for management

Exclusion criteria

* preference for pills over liquid formulation * history of Nissen fundoplication surgery * needed immediate airway intervention * require oral medications to be given via a G or J tube * if patient care would be compromised * enrolled in the study on a previous visit.

Design outcomes

Primary

MeasureTime frame
The primary objective of this study was to assess whether smaller volumes of oral dexamethasone resulted in better tolerability, specifically less vomiting, in pediatric patients with an acute exacerbation of asthma.During Emergency Department visit

Secondary

MeasureTime frame
To evaluate asthma symptom control post emergency room visit for acute asthma exacerbation.7-14 days following emergency dept visit

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026